Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
phospholipase/inflammation
Länken sparas på Urklipp
Sida 1 från 102 resultat
Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to the field of treating inflammation in humans and animals. More particularly, the invention concerns a pure preparation of a phospholipase inhibitory protein (PIP) which is effective in controlling inflammation.
BACKGROUND ART
The general physiological
Monoclonal antibodies against type I phospholipase A.sub.2 as a diagnostic and anti-inflammatory therapeutic agent
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The invention concerns the use of monoclonal antibodies against type I phospholipase A.sub.2 for the production of an anti-inflammatory therapeutic agent which is particularly suitable for application in acute pancreatitis.
BACKGROUND OF THE INVENTION
There is neither a causal
Phospholipase C inhibitors for use in treating inflammatory disorders
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention relates to a series of phosphoinositide-specific phospholipase C (PLC) inhibitors useful in treating or ameliorating an inflammatory disorder. More particularly, the PLC inhibitors are heterocyclyl-substituted anilino compounds useful in treating or ameliorating
Peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to peptide inhibitors of phospholipase A.sub.2 purified from inflammatory sites.
BACKGROUND ART
Phospholipase A.sub.2 is an enzyme which hydrolyzes .beta.-ester bonds in phospholipid to give fatty acids and lysophospho-lipids. Especially, it releases
Protein inhibitors of phospholipase A.sub.2 purified from inflammatory sites and production process
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to protein inhibiting phospholipase A.sub.2 which participates in the progress of inflammation, the production process and gene therefor. More particularly, the invention concerns rat or human protein inhibitors of phospholipase A.sub.2 purified from
Methods for treating diseases having an inflammatory component related to phospholipase A2
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Recent studies with rodent Experimental Autoimmune Encephalitis (EAE) models of Multiple Sclerosis (MS) suggest phospholipase A2 (PLA2) enzymes are involved in the genesis of both the behavioral deficits and the inflammation that characterize this disease (Pinto, et al.,
Compositions and methods for inhibition of phospholipase A2 mediated inflammation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates generally to the field of non-steroidal anti-inflammatory agents for inhibition of phospholipase A2 enzymes, and the use of such agents in controlling inflammation.
BACKGROUND OF THE INVENTION
Injury to one part of the body often results in
A87689 compounds employed as a phospholipase A.sub.2 (PLA.sub.2) inhibitor to treat inflammatory diseases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD OF THE INVENTION
The present invention relates to the isolation and characterization of a microbially-synthesized compound, its derivatives and pharmaceutically acceptable salts thereof, and processes for enzyme inhibition. More particularly, this invention includes a novel
Human anti-inflammatory phospholipase inhibitor protein
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to the field of treating inflammation in humans and animals. More particularly, the invention concerns a pure preparation of a phospholipase inhibitory protein (PIP) which is effective in controlling inflammation.
BACKGROUND ART
The general physiological
Pharmaceutical composition for preventing or treating inflammatory diseases or infectious diseases, containing m-3M3FBS, which is activator of phospholipase C, as active ingredient
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/KR2012/001855 filed Mar. 14, 2012, claiming priority based on Korean Patent Application No. 10-2011-24239 filed Mar. 18, 2011 the contents of all of which are incorporated herein by
Methods for the use of inhibitors of cytosolic phospholipase A2
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to methods for the use of chemical inhibitors of the activity of various phospholipase enzymes, particularly cytosolic phospholipase A.sub.2 enzymes (cPLA.sub.2), more particularly including inhibitors of cytosolic phospholipase A.sub.2 alpha
Methods for the use of inhibitors of cytosolic phospholipase A2
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to methods for the use of chemical inhibitors of the activity of various phospholipase enzymes, particularly cytosolic phospholipase A.sub.2 enzymes (cPLA.sub.2), more particularly including inhibitors of cytosolic phospholipase A.sub.2 alpha
Inhibitors of phosphoinositide-specific phospholipase C
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Phospholipases C (EC 3.1.4.3) are a family of enzymes which hydrolyze the sn-3 phosphodiester bond in membrane phospholipids producing diacylglycerol and a phosphorylated polar head group. Mammalian phospholipase C (PLC) enzymes exhibit specificity for the polar head
Calcium independent cytosolic phospholipase A2/B enzymes
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to a purified calcium independent cytosolic phospholipase A.sub.2 /B enzymes which are useful for assaying chemical agents for anti-inflammatory activity.
BACKGROUND OF THE INVENTION
The phospholipase A.sub.2 enzymes comprise a widely distributed family of enzymes which
Calcium independent cytosolic phospholipase A2/B enzymes
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention relates to a purified calcium independent cytosolic phospholipase A.sub.2 /B enzymes which are useful for assaying chemical agents for anti-inflammatory activity.
BACKGROUND OF THE INVENTION
The phospholipase A.sub.2 enzymes comprise a widely distributed family of enzymes which
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
